Application of Natural Products in SARS-CoV-2 examines the potential for natural products to treat COVID-19, bringing together the most recent research. SARS-CoV-2 is a novel disease H54 that is still being researched despite being globally prevalent. There are still few proven treatments, so repurposing existing drugs and treatments is essential. While there have been many articles published on the subject, this book is the first to bring together data and research on the topic. It includes information about molecular mechanism, dosage and safety profiles, and an essential resource for all scientists and researchers working to combat SARS-CoV-2.
1. Application of Natural Products in SARS-CoV-2 - p. i 2. Cover - p. i 3. Title Page - p. i 4. Copyright Page - p. iv 5. Contents - p. v 6. List of contributors - p. xxi 7. Preface - p. xxvii 8. Chapter 1 Natural products and SARS-CoV-2 - p. 1 9. Chapter 2 Saponin and its derivatives (glycyrrhizin) and SARS-CoV-2 - p. 25 10. Chapter 3 Quinone and SARS-CoV-2 - p. 47 11. Chapter 4 Flavonoids and other polyphenols against SARS-CoV-2 - p. 83 12. Chapter 5 Alkaloids and COVID-19 - p. 125 13. Chapter 6 Terpenes, meroterpenoids, and artemisinin and SARS-CoV-2 - p. 143 14. Chapter 7 Anthraquinones and SARS-CoV-2 - p. 171 15. Chapter 8 Coumarins and chalcones against SARS-CoV-2 - p. 185 16. Chapter 9 Diarylheptanoid and SAR-CoV-2 - p. 199 17. Chapter 10 Lectins and polysaccharides against SARS-CoV-2 - p. 223 18. Chapter 11 Phytoestrogen and SARS-CoV-2 - p. 253 19. Chapter 12 Phages and SARS-CoV-2 - p. 273 20. Chapter 13 Pyridone and SARS-CoV-2 - p. 293 21. Chapter 14 Vitamins and SARS-CoV-2 - p. 313 22. Chapter 15 Lactoferrin and SARS-CoV-2 - p. 339 23. Chapter 16 Recent artificial intelligence methods and coronaviruses - p. 353 24. Chapter 17 Peptides, lipopeptides, and severe acute respiratory syndrome coronavirus-2 - p. 381 25. Chapter 18 Polyketides and SARS-CoV-2 - p. 423 26. Chapter 19 Polyenes and SARS-CoV-2 - p. 445 27. Chapter 20 In silico analysis for such natural compounds and COVID-19 - p. 463 28. Chapter 21 Natural products as vaccine and different delivery methods - p. 491 29. Index - p. 509
Application of Natural Products in SARS-CoV-2 examines the potential for natural products to treat COVID-19, bringing together the most recent research. SARS-CoV-2 is a novel disease H54 that is still being researched despite being globally prevalent. There are still few proven treatments, so repurposing existing drugs and treatments is essential. While there have been many articles published on the subject, this book is the first to bring together data and research on the topic. It includes information about molecular mechanism, dosage and safety profiles, and an essential resource for all scientists and researchers working to combat SARS-CoV-2.
1. Application of Natural Products in SARS-CoV-2 - p. i 2. Cover - p. i 3. Title Page - p. i 4. Copyright Page - p. iv 5. Contents - p. v 6. List of contributors - p. xxi 7. Preface - p. xxvii 8. Chapter 1 Natural products and SARS-CoV-2 - p. 1 9. Chapter 2 Saponin and its derivatives (glycyrrhizin) and SARS-CoV-2 - p. 25 10. Chapter 3 Quinone and SARS-CoV-2 - p. 47 11. Chapter 4 Flavonoids and other polyphenols against SARS-CoV-2 - p. 83 12. Chapter 5 Alkaloids and COVID-19 - p. 125 13. Chapter 6 Terpenes, meroterpenoids, and artemisinin and SARS-CoV-2 - p. 143 14. Chapter 7 Anthraquinones and SARS-CoV-2 - p. 171 15. Chapter 8 Coumarins and chalcones against SARS-CoV-2 - p. 185 16. Chapter 9 Diarylheptanoid and SAR-CoV-2 - p. 199 17. Chapter 10 Lectins and polysaccharides against SARS-CoV-2 - p. 223 18. Chapter 11 Phytoestrogen and SARS-CoV-2 - p. 253 19. Chapter 12 Phages and SARS-CoV-2 - p. 273 20. Chapter 13 Pyridone and SARS-CoV-2 - p. 293 21. Chapter 14 Vitamins and SARS-CoV-2 - p. 313 22. Chapter 15 Lactoferrin and SARS-CoV-2 - p. 339 23. Chapter 16 Recent artificial intelligence methods and coronaviruses - p. 353 24. Chapter 17 Peptides, lipopeptides, and severe acute respiratory syndrome coronavirus-2 - p. 381 25. Chapter 18 Polyketides and SARS-CoV-2 - p. 423 26. Chapter 19 Polyenes and SARS-CoV-2 - p. 445 27. Chapter 20 In silico analysis for such natural compounds and COVID-19 - p. 463 28. Chapter 21 Natural products as vaccine and different delivery methods - p. 491 29. Index - p. 509
